Zu lab Publications


ALK phosphorylates SMAD4 on tyrosine to disable TGF-ß tumour suppressor functions
Zhang, Q, Xiao, M, Gu, S, Xu, Y, Liu, T, Li, H, Yu, Y, Qin, L, Zhu, Y, Chen, F, Wang, Y, Ding, C, Wu, H, Ji, H, Chen, Z, Zu, Y, Malkoski, S, Li, Y, Liang, T, Ji, J, Qin, J, Xu, P, Zhao, B, Shen, L, Lin, X & Feng, XH 2019, Nature Cell Biology, vol. 21, no. 2, pp. 179-189. https://doi.org/10.1038/s41556-018-0264-3

Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
Yang, S, Li, H, Xu, L, Deng, Z, Han, W, Liu, Y, Jiang, W & Zu, Y 2018, Molecular Therapy - Nucleic Acids, vol. 13, pp. 164-175. https://doi.org/10.1016/j.omtn.2018.08.023

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
Wang, X, Cao, X, Sun, R, Tang, C, Tzankov, A, Zhang, J, Manyam, GC, Xiao, M, Miao, Y, Jabbar, K, Tan, X, Pang, Y, Visco, C, Xie, Y, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, van Krieken, JH, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Winter, JN, Piris, MA, Li, S, Miranda, RN, Medeiros, LJ, Li, Y, Xu-Monette, ZY & Young, KH 2018, Neoplasia (United States), vol. 20, no. 6, pp. 574-593. https://doi.org/10.1016/j.neo.2018.03.002

DNA Thioaptamer with Homing Specificity to Lymphoma Bone Marrow Involvement
Mai, J, Li, X, Zhang, G, Huang, Y, Xu, R, Shen, Q, Lokesh, GL, Thiviyanathan, V, Chen, L, Liu, H, Zu, Y, Ma, X, Volk, DE, Gorenstein, DG, Ferrari, M & Shen, H 2018, Molecular Pharmaceutics, vol. 15, no. 5, pp. 1814-1825. https://doi.org/10.1021/acs.molpharmaceut.7b01169

Tumor-specific t-cells engineered to overcome tumor immune evasion induce clinical responses in patients with relapsed hodgkin lymphoma
Bollard, CM, Tripic, T, Cruz, CR, Dotti, G, Gottschalk, S, Torrano, V, Dakhova, O, Carrum, G, Ramos, CA, Liu, H, Wu, MF, Marcogliese, AN, Barese, C, Zu, Y, Lee, DY, O’Connor, O, Gee, AP, Brenner, M, Heslop, H & Rooney, CM 2018, Journal of Clinical Oncology, vol. 36, no. 11, pp. 1128-1139. https://doi.org/10.1200/JCO.2017.74.3179

Updates in Polycythemia Vera
Nagrale, V, Olsen, RJ & Zu, Y 2018, . in C-CJ Chang & R Ohgami (eds), Precision Molecular Pathology of Myeloid Neoplasms. 1st edn, vol. 12, Springer, Switzerland, pp. 115-139. https://doi.org/10.1007/978-3-319-62146-3

A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells
Liu, H, Mai, J, Shen, J, Wolfram, J, Li, Z, Zhang, G, Xu, R, Li, Y, Mu, C, Zu, Y, Li, X, Lokesh, GL, Thiviyanathan, V, Volk, DE, Gorenstein, DG, Ferrari, M, Hu, Z & Shen, H 2018, Theranostics, vol. 8, no. 1, pp. 31-44. https://doi.org/10.7150/thno.21342

Spin-Valve based magnetoresistive nanoparticle detector for applications in biosensing
Qiu, W, Chang, L, Liang, YC, Litvinov, J, Guo, J, Chen, YT, Vu, B, Kourentzi, K, Xu, S, Lee, TR, Zu, Y, Willson, RC & Litvinov, D 2017, Sensors and Actuators, A: Physical, vol. 265, pp. 174-180. https://doi.org/10.1016/j.sna.2017.08.018

Diagnostic algorithm of common mature B-cell lymphomas by immunohistochemistry
Wang, HY & Zu, Y 2017, Archives of Pathology and Laboratory Medicine, vol. 141, no. 9, pp. 1236-1246. https://doi.org/10.5858/arpa.2016-0521-RA


Ultrasensitive magnetic nanoparticle detector for biosensor applications
Liang, YC, Chang, L, Qiu, W, Kolhatkar, AG, Vu, B, Kourentzi, K, Lee, TR, Zu, Y, Willson, RC & Litvinov, D 2017, Sensors (Switzerland), vol. 17, no. 6, 1296. https://doi.org/10.3390/s17061296

Aptamer internalization via endocytosis inducing s-phase arrest and priming maver-1 lymphoma cells for cytarabine chemotherapy
Li, H, Yang, S, Yu, G, Shen, L, Fan, J, Xu, L, Zhang, H, Zhao, N, Zeng, Z, Hu, T, Wen, J & Zu, Y 2017, Theranostics, vol. 7, no. 5, pp. 1204-1213. https://doi.org/10.7150/thno.17069


Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma
Xu-Monette, ZY, Li, L, Byrd, JC, Jabbar, KJ, Manyam, GC, De Winde, CM, Van Den Brand, M, Tzankov, A, Visco, C, Wang, J, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Winter, JN, Wang, M, Hagemeister, FB, Piris, MA, Van Krieken, JH, Medeiros, LJ, Li, Y, Van Spriel, AB & Young, KH 2016, Blood, vol. 128, no. 26, pp. 3083-3100. https://doi.org/10.1182/blood-2016-05-715094

B7-H4 expression in ovarian serous carcinoma: a study of 306 cases
Liang, L, Jiang, Y, Chen, JS, Niu, N, Piao, J, Ning, J, Zu, Y, Zhang, J & Liu, J 2016, Human pathology, vol. 57, pp. 1-6. https://doi.org/10.1016/j.humpath.2016.06.011

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma
Xia, Y, Xu-Monette, ZY, Tzankov, A, Li, X, Manyam, GC, Murty, V, Bhagat, G, Zhang, S, Pasqualucci, L, Visco, C, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Richards, KL, Hsi, ED, Choi, WWL, van Krieken, JH, Huh, J, Ponzoni, M, Ferreri, AJM, Møller, MB, Parsons, BM, Winter, JN, Piris, MA, Westin, J, Fowler, N, Miranda, RN, Ok, CY, Li, Y, Li, J, Medeiros, LJ & Young, KH 2016, Leukemia. https://doi.org/10.1038/leu.2016.243

Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
Chen, Z, Shao, C, Wang, W, Zuo, Z, Mou, X, Hu, SJ, DiGiuseppe, JA, Zu, Y, Medeiros, LJ & Hu, S 2016, Leukemia. https://doi.org/10.1038/leu.2016.231

Overt leukemic phase: an unusual presentation of angioimmunoblastic lymphoma
Arora, K, Zhang, L, Xie, W, Baker, KR, Zu, Y & Hao, S 2016, Journal of Hematopathology, vol. 9, no. 3, pp. 139-142. https://doi.org/10.1007/s12308-016-0278-3

Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B-cell lymphoma
Xu-Monette, ZY, Deng, Q, Manyam, GC, Tzankov, A, Li, L, Xia, Y, Wang, XX, Zou, D, Visco, C, Dybkær, K, Li, J, Zhang, L, Liang, H, Montes-Moreno, S, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Van Krieken, JH, Huh, J, Ponzoni, M, Ferreri, AJM, Parsons, BM, Møller, MB, Wang, SA, Miranda, RN, Piris, MA, Winter, JN, Medeiros, LJ, Li, Y & Young, KH 2016, Clinical Cancer Research, vol. 22, no. 14, pp. 3593-3605. https://doi.org/10.1158/1078-0432.CCR-15-2296